Скачать или смотреть Widespread adoption of CAR-T therapy in the UK: fostering specialist networks

In this video, Andrea Kuhnl, MD, King's College Hospital, London, UK, briefly discusses the potential challenges associated with the widespread adoption of CAR T-cell therapy and other immunotherapies in the UK. Dr Kuhnl highlights the need to consider individual patient eligibility and the complexity of selecting the best product and sequence of immunotherapies, which may require collaborative network structures involving CAR-T centers and referring centers to optimize treatment recommendations. This interview took place during the 18th International Conference on Malignant Lymphoma (18-ICML) in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.